Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Foster Corporationís New Specialty Extrusion Facility Offers Unique Service to Medical Device Industry

Foster Corporation's new specialty tubing for medical devices facility. (Photo: Business Wire)
Foster Corporation's new specialty tubing for medical devices facility. (Photo: Business Wire)

Abstract:
Foster Corporation, the leading developer and manufacturer of critical polymer compounds, has opened a new facility at its Putnam, Connecticut, headquarters dedicated to producing specialty tubing for the medical device industry.

Foster Corporationís New Specialty Extrusion Facility Offers Unique Service to Medical Device Industry

PUTNAM, CT | Posted on December 4th, 2008

Foster has been working with OEMs to develop and manufacture compounds for medical devices for over 20 years. During this time, many requests have come into Foster for prototype tubing from customers seeking to shorten and simplify the device development process and facilitate their evaluation of new compounds and material technologies.

To meet this need, Foster has put in place a complete tubing manufacturing line with up-to-date testing and measuring equipment. Foster's qualified engineering team has over 30 years of combined medical materials knowledge, in addition to 15 years of practical experience in the manufacture of medical tubing.

Foster's materials engineering strength and experience in processing challenging compounds, coupled with this new capability, offers device developers the opportunity to optimize materials and tubing concurrently. It also takes steps out of the development process and simplifies production startup.

Evaluation of new additive technologies, such as antimicrobials, also will be easier with Foster serving as a single source for both compound and prototype extrusions.

Commenting on Foster's new specialty extrusion facility, Director of Engineering, Brian Labrec, said: "We are the first in the industry with the capability to optimize the material formulation and the compounding process with the performance of the tubing operation."

According to Ken Pickering, Foster's President and Chief Operating Officer, this new Foster specialty extrusion facility is now in full operation. He said, "We are very excited about the opportunity to shorten our customer's development cycle time for medical devices by utilizing our materials expertise, engineering capabilities and innovative process know-how. As the leader in development of specialty materials for medical device companies around the globe, Foster sees this as an extension of our core competencies, not a venture into a new business."

####

For more information, please click here

Contacts:
Grant Marketing
Bob Grant
617-796-0186
Public Relations

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Nanomedicine

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

NUS researchers invent new test kit for quick, accurate and low-cost screening of diseases: Test results are denoted by a color change and could be further analyzed by a smartphone app, making it attractive as a point-of-care diagnostic device September 19th, 2018

Announcements

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project